Sharecare Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 6/6

Sharecare hat ein Gesamteigenkapital von $463.8M und eine Gesamtverschuldung von $586.0K, was einen Verschuldungsgrad von 0.1% ergibt. Die Gesamtaktiva und Gesamtpassiva betragen $578.6M bzw. $114.9M.

Wichtige Informationen

0.1%

Verhältnis von Schulden zu Eigenkapital

US$586.00k

Verschuldung

Zinsdeckungsgrad	n/a
Bargeld	US$100.32m
Eigenkapital	US$463.78m
Gesamtverbindlichkeiten	US$114.86m
Gesamtvermögen	US$578.63m

Jüngste Berichte zur Finanzlage

Recent updates

We Think Sharecare (NASDAQ:SHCR) Can Afford To Drive Business Growth

Nov 23

We're Hopeful That Sharecare (NASDAQ:SHCR) Will Use Its Cash Wisely

Aug 18

There's No Escaping Sharecare, Inc.'s (NASDAQ:SHCR) Muted Revenues

Jul 22

We Think Sharecare (NASDAQ:SHCR) Needs To Drive Business Growth Carefully

Feb 22

Sharecare awarded three-year NCQA accreditation for wellness and health promotion

Sep 19

Sharecare Non-GAAP EPS of -$0.02 beats by $0.07, revenue of $103.8M beats by $0.87M

Aug 10

Analysts Have Lowered Expectations For Sharecare, Inc. (NASDAQ:SHCR) After Its Latest Results

Apr 03

Sharecare, Inc. (NASDAQ:SHCR) Analysts Just Slashed This Year's Estimates

Apr 02

Sharecare CEO Jeff Arnold - Healthcare Ripe For Disruption (Video)

Nov 23

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: SHCRDie kurzfristigen Aktiva des Unternehmens ($240.2M) übersteigen seine kurzfristigen Passiva ($106.8M).

Langfristige Verbindlichkeiten: SHCRDie kurzfristigen Vermögenswerte des Unternehmens ($240.2M) übersteigen seine langfristigen Verbindlichkeiten ($8.1M).

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: SHCR über mehr Barmittel verfügt als seine Gesamtverschuldung.

Schulden abbauen: SHCR Das Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 1079.2% auf 0.1% zurückgegangen.

Bilanz

Liquiditätsreserve-Analyse

Bei Unternehmen, die in der Vergangenheit im Durchschnitt Verluste gemacht haben, wird geprüft, ob sie über einen Liquiditätsvorlauf von mindestens einem Jahr verfügen.

Stabile Start- und Landebahn für Bargeld: SHCR auf der Grundlage seines derzeitigen freien Cashflows über eine ausreichende Liquiditätsreserve für mehr als ein Jahr verfügt.

Vorhersage Cash Runway: SHCR verfügt über eine ausreichende Liquiditätsreserve für 1.6 Jahre, wenn der freie Cashflow weiterhin mit historischen Raten von 20.8% pro Jahr abnimmt.

Sharecare Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 6/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Sharecare Receives a Letter from the Listing Qualifications Department of the Nasdaq Stock Market

Sharecare, Inc. announced delayed annual 10-K filing

We Think Sharecare (NASDAQ:SHCR) Can Afford To Drive Business Growth

We're Hopeful That Sharecare (NASDAQ:SHCR) Will Use Its Cash Wisely

We Think Sharecare (NASDAQ:SHCR) Needs To Drive Business Growth Carefully

Recent updates

Altaris, LLC entered into a definitive agreement to acquire Sharecare, Inc. (NasdaqGS:SHCR) for approximately $520 million.

Price target decreased by 14% to US$1.50

Sharecare, Inc., Annual General Meeting, Jun 13, 2024

Sharecare, Inc. to Report Q1, 2024 Results on May 09, 2024

Rosen Law Firm Files A Class Action Lawsuit Against Sharecare Inc

Rosen Law Firm Files A Class Action Lawsuit Against Sharecare Inc

Sharecare Receives a Letter from the Listing Qualifications Department of the Nasdaq Stock Market

Sharecare, Inc Appoints Nicole Torraco to its Board of Directors

Sharecare, Inc. announced delayed annual 10-K filing

Sharecare, Inc. to Report Q4, 2023 Results on Mar 13, 2024

Founder & Executive Chairman exercised options and sold US$216k worth of stock

Founder & Executive Chairman exercised options and sold US$660k worth of stock

We Think Sharecare (NASDAQ:SHCR) Can Afford To Drive Business Growth

Price target decreased by 10.0% to US$3.00

Sharecare, Inc. Announces CEO Changes

Third quarter 2023 earnings released: US$0.07 loss per share (vs US$0.078 loss in 3Q 2022)

Sharecare, Inc. to Report Q3, 2023 Results on Nov 09, 2023

New minor risk - Share price stability

Consensus EPS estimates fall by 12%

We're Hopeful That Sharecare (NASDAQ:SHCR) Will Use Its Cash Wisely

Second quarter 2023 earnings: EPS misses analyst expectations

Sharecare, Inc. Provides Revenue Guidance for the Third Quarter Ending September 30, 2023 and Fiscal Year Ending December 31, 2023

Sharecare Expands Suite of Customer Activation and Management Solutions to Support Patient Education and Improve the Care Journey

Sharecare, Inc. to Report Q2, 2023 Results on Aug 09, 2023

There's No Escaping Sharecare, Inc.'s (NASDAQ:SHCR) Muted Revenues

Sharecare, Inc. (NasdaqGS:SHCR) announces an Equity Buyback for $50 million worth of its shares.

Consensus EPS estimates fall by 16%

Consensus EPS estimates fall by 61%

Sharecare, Inc. Revises Revenue Guidance for the Fiscal Year Ending December 31, 2023

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Key Executive exercised options and sold US$94k worth of stock

Full year 2022 earnings: EPS misses analyst expectations

We Think Sharecare (NASDAQ:SHCR) Needs To Drive Business Growth Carefully

Sharecare Launches VR Program to Improve Well-Being of American Workforce and Bring Innovation to Exercise

Sharecare Launches Virtual Model of Its Medicare-Reimbursable Cardiac Rehabilitation Program, Ornish Lifestyle Medicine

Price target increased to US$3.50

Sharecare, Inc. Appoints Brent Layton to Its Board of Directors and Audit Committee

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Sharecare, Inc. to Report Q3, 2022 Results on Nov 10, 2022

Price target decreased to US$3.40

Sharecare Announces Nine New Digital Solutions Designed to Engage, Educate, and Support People in Managing Their Health

Sharecare Receives Three-Year NCQA Accreditation for Wellness and Health Promotion

Sharecare awarded three-year NCQA accreditation for wellness and health promotion

Sharecare Launches Self-Service Software Platform to Enable Independent Decentralized Clinical Research

Consensus EPS estimates fall by 69%

Second quarter 2022 earnings: EPS misses analyst expectations

Sharecare Non-GAAP EPS of -$0.02 beats by $0.07, revenue of $103.8M beats by $0.87M

Sharecare, Inc. to Report Q2, 2022 Results on Aug 10, 2022

Sharecare Names Harsha Panyadahundi Chief Technology Officer

Consensus forecasts updated

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Sharecare, Inc. (NasdaqGS:SHCR) announces an Equity Buyback for $50 million worth of its shares.

Sharecare Announces Sharecare+, its Whole Health, Payor-Agnostic Advocacy Solution

Price target decreased to US$6.67

Forecast breakeven date pushed back to 2023

Sharecare, Inc. to Report Q1, 2022 Results on May 12, 2022

Consensus revenue estimates fall by 12%

Analysts Have Lowered Expectations For Sharecare, Inc. (NASDAQ:SHCR) After Its Latest Results

Sharecare, Inc. (NASDAQ:SHCR) Analysts Just Slashed This Year's Estimates

Full year 2021 earnings: EPS misses analyst expectations

Sharecare, Inc. Provides Earning Guidance for the First Quarter Ending March 31, 2022 and Year Ending December 31, 2022

Sharecare, Inc. to Report Q4, 2021 Results on Mar 31, 2022

Price target decreased to US$10.50

Sharecare CEO Jeff Arnold - Healthcare Ripe For Disruption (Video)

No longer forecast to breakeven

Sharecare, Inc. (NasdaqGS:SHCR) acquired CareLinx Incorporated from Europ Assistance Holding S.A.S for $65 million.

Director Bradley Karro has left the company

Director James Scott English has left the company

Director Brian Pieninck has left the company